Table 3.
Multivariate analysis, cognitive impairment outcome.
| Characteristics | Crude model |
Adjusted model |
||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Gendera | ||||
| Female | 1 | 1 | ||
| Male | 1.15 (0.99–2.20) | 0.06 | 0.75 (0.43–1.32) | 0.32 |
| Age (years)a | ||||
| <50 | 1 | 1 | ||
| ≥50 | 2.04 (1.59–2.63) | 0.001 | 2.28 (1.59–2.63) | 0.002 |
| Race/ethnicitya | ||||
| White | 1 | 1 | ||
| Non-white | 1.71 (1.04–2.83) | 0.05 | 1.22 (0.98–2.03) | 0.08 |
| Education level (years)a | ||||
| 0–7 | 6.72 (3.98–11.32) | <0.001 | 6.06 (3.98–11.32) | <0.001 |
| ≥8 | 1 | 1 | ||
| CD4 nadirb | ||||
| ≤200 | 2.77 (1.57–4.89) | <0.001 | 2.78 (1.47–5.25) | 0.02 |
| >200 | 1 | 1 | ||
| Current CD4b | ||||
| ≤200 | 1 | – | ||
| >200 | 0.64 (0.39–1.37) | 0.27 | – | |
a
Adjusted for gender, age, race/ethnicity, education level.
b
Adjusted for duration of HIV infection, CD4 nadir, current CD4, initial VL, current VL, use of HAART, gender, age, race/ethnicity, education level.